Iovance Biotherapeutics, Inc.
Key Metrics
Market Snapshot
About
Iovance Biotherapeutics is a clinical-stage biotechnology company developing tumor-infiltrating lymphocyte (TIL) therapies for cancer treatment. The company's approach involves extracting immune cells from a patient's tumor, expanding them in the lab, and infusing them back to fight cancer. Iovance's lead programs target solid tumors including melanoma, cervical cancer, and head and neck cancers. The company's TIL therapy represents a personalized immunotherapy approach distinct from CAR-T and other cell therapies.